NCT01623713 - Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia | Biotech Hunter

Enrollment

260

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions

SchizophreniaIloperidoneEfficacy

Interventions

DRUG

iloperidone

Iloperidone is being development as a treatment of schizophrenia. This trial will verify the safety and efficacy of iloperidone in patients with schizophrenia.

DRUG

Risperidone

Risperidone is used for the treatment of schizophrenia.Risperidone is unique among most other atypicals in that it has high affinity for the D2 receptor whereas most other atypicals have 'loose binding' of the D2 receptor. It has actions at several 5-HT (serotonin) receptor subtypes.

Trial Locations (1)

100191

Sixth Hospital of Peking University, Beijing